Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis

Antimicrob Agents Chemother. 1996 Aug;40(8):1971-2. doi: 10.1128/AAC.40.8.1971.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Aztreonam / administration & dosage
  • Aztreonam / therapeutic use
  • Dialysis Solutions / chemistry
  • Humans
  • Monobactams / administration & dosage
  • Monobactams / therapeutic use
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy*
  • Peritonitis / etiology
  • Peritonitis / metabolism
  • Teicoplanin / administration & dosage
  • Teicoplanin / pharmacokinetics*
  • Teicoplanin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Dialysis Solutions
  • Monobactams
  • Teicoplanin
  • Aztreonam